StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zomedica's price to sales ratio was 2.1× on Oct 19, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.4× to 85.4×, with a median of 5.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20262.1×−1.3
2025Dec 31, 20253.4×−1.0
2024Dec 31, 20244.4×−3.8
2023Dec 29, 20238.2×−1.3
2022Dec 30, 20229.5×–

More Zomedica figures

See a number that looks wrong?